UCI – Das Tumorzentrum Bern - Navigation

Ochsenbein, Adrian

{"headers":{"title":"Title","year":"Year","type":"Type"},"rows":[{"title":"Schmid, D., Sobottka, B., Manzo, M., Tr\u00fcb, M., Leonards, K., Herzig, P., Oyewole, O. R.-A., Jermann, P., Hayoz, S., Savic Prince, S., Tochtermann, G., Natoli, M., Pless, M., Bettini, A., Fr\u00fch, M., Mauti, L. A., Britschgi, C., Peters, S., Mark, M., \u2026 Zippelius, A. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/219511\u0022\u003ETumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy\u003C\/a\u003E. \u003Ci\u003ENature Communications\u003C\/i\u003E, \u003Ci\u003E16\u003C\/i\u003E(1), 8673.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Reinhardt, C., \u0026 Ochsenbein, A. F. (2025). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/209481\u0022\u003EImmune checkpoints regulate acute myeloid leukemia stem cells.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ELeukemia\u003C\/i\u003E, \u003Ci\u003E39\u003C\/i\u003E, 1277-1293.","year":2025,"type":"Journal Article (Review)"},{"title":"Rubino, V., H\u00fcppi, M., H\u00f6pner, S., Tortola, L., Schn\u00fcriger, N., Legenne, H., Taylor, L., Voggensperger, S., Keller, I., Bruggmann, R., Kronig, M.-N., Bacher, U., Kopf, M., Ochsenbein, A. F., \u0026 Riether, C. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/189600\u0022\u003EIL-21\/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T\u00a0cell therapy\u003C\/a\u003E. \u003Ci\u003ECell Reports Medicine\u003C\/i\u003E, \u003Ci\u003E5\u003C\/i\u003E(11), 101826.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Radpour, R., Simillion, C., Wang, B., Abbas, H. A., Riether, C., \u0026 Ochsenbein, A. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/178575\u0022\u003EIL-9 Secreted by Leukemia Stem Cells Induces Th1-Skewed CD4+ T-Cells, which Promote Their Expansion\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E144\u003C\/i\u003E(8), 888-903.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Bianchi, M., Reichen, C., Croset, A., Fischer, S., Eggenschwiler, A., Gr\u00fcbler, Y., Marpakwar, R., Looser, T., Spitzli, P., Herzog, C., Villemagne, D., Schiegg, D., Abduli, L., Iss, C., Neculcea, A., Franchini, M., Lekishvili, T., Ragusa, S., Zitt, C., \u2026 Goubier, A. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/177095\u0022\u003EThe CD33xCD123xCD70 Multispecific CD3-Engaging DARPin MP0533 Induces Selective T Cell-Mediated Killing of AML Leukemic Stem Cells\u003C\/a\u003E. \u003Ci\u003ECancer Immunology Research\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E(7), 921-943.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Mastall, M., Roth, P., Bink, A., Fischer Maranta, A., L\u00e4ubli, H., Hottinger, A. F., Hundsberger, T., Migliorini, D., Ochsenbein, A., Seystahl, K., Imbach, L., Hortobagyi, T., Held, L., Weller, M., \u0026 Wirsching, H.-G. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/173413\u0022\u003EA phase Ib\/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol\u003C\/a\u003E. \u003Ci\u003EBMC Cancer\u003C\/i\u003E, \u003Ci\u003E24\u003C\/i\u003E(1), 82.","year":2024,"type":"Journal Article (Further Contribution)"},{"title":"Esposito, R., Lanzos Camaioni, A. A., Uroda, T., Ramnarayanan, S., B\u00fcchi, I., Polidori, T., Guillen Ramirez, H. A., Mihaljevic, A., Merlin, B. M., Mela, L., Zoni, E., Hovhannisyan, L., McCluggage, F., Medo, M., Basile, G., Meise, D. F., Zwyssig, S. M., Wenger, C., Schwarz, K. A., \u2026 Johnson, R. B. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/169820\u0022\u003EAuthor Correction: Tumour mutations in long noncoding RNAs enhance cell fitness\u003C\/a\u003E. \u003Ci\u003ENature Communications\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(1), 5463.","year":2023,"type":"Journal Article (Further Contribution)"},{"title":"N\u00e4f, P., Radpour, R., Jaeger-Ruckstuhl, C. A., Bodmer, N. S., B\u00e4rlocher, G. M., Doehner, H., Doehner, K., Riether, C., \u0026 Ochsenbein, A. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/169656\u0022\u003EIL-33-ST2 signaling promotes stemness in subtypes of myeloid leukemia cells through the Wnt and Notch pathways\u003C\/a\u003E. \u003Ci\u003EScience Signaling\u003C\/i\u003E, \u003Ci\u003E16\u003C\/i\u003E(800), eadd7705.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Pabst, T. N., Vey, N., Ad\u00e8s, L., Bacher, V. U., Bargetzi, M., Fung, S., Gaidano, G., Gandini, D., Hultberg, A., Johnson, A., Ma, X., M\u00fcller, R., Nottage, K., Papayannidis, C., Recher, C., Riether, C., Shah, P., Tryon, J., Xiu, L., \u0026 Ochsenbein, A. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/121569\u0022\u003EResults from a phase I\/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapy\u003C\/a\u003E. \u003Ci\u003EHaematologica - the Hematology Journal\u003C\/i\u003E, \u003Ci\u003E108\u003C\/i\u003E(7), 1793-1802.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Esposito, R., Lanzos Camaioni, A. A., Uroda, T., Ramnarayanan, S., B\u00fcchi, I., Polidori, T., Guillen-Ramirez, H., Mihaljevic, A., Merlin, B. M., Lia, M., Zoni, E., Hovhannisyan, L., McCluggage, F., Medo, M., Basile, G., Meise, D. F., Zwyssig, S. M., Wenger, C., Schwarz, K. A., \u2026 Johnson, R. B. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/167715\u0022\u003ETumour mutations in long noncoding RNAs enhance cell fitness\u003C\/a\u003E. \u003Ci\u003ENature Communications\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(1), 3342.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Yang, H., Gao, Y., Xu, D., Xu, K., Shun-Qing, L., Yang, Z., Scherz, A., Hall, S., Forster, S., Berezowska, S. A., Yao, F., Ochsenbein, A., Marti, T., Kocher, G., Schmid, R., Dorn, P., \u0026 Peng, R.-W. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/190597\u0022\u003EMEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma\u003C\/a\u003E. \u003Ci\u003ECell Death Discovery\u003C\/i\u003E, \u003Ci\u003E9\u003C\/i\u003E(1), 55.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Forster, S., Radpour, R., \u0026 Ochsenbein, A. (2023). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/170197\u0022\u003EMolecular and immunological mechanisms of clonal evolution in multiple myeloma.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EFrontiers in Immunology\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(1243997), 1243997.","year":2023,"type":"Journal Article (Review)"},{"title":"Zens, P. I., Bello, C. M., Scherz, A., von Gunten, M., Ochsenbein, A., Schmid, R., \u0026 Berezowska, S. A. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/86490\u0022\u003EThe effect of neoadjuvant therapy on PD-L1 expression and CD8+lymphocyte density in non-small cell lung cancer\u003C\/a\u003E. \u003Ci\u003EModern Pathology\u003C\/i\u003E, \u003Ci\u003E35\u003C\/i\u003E(12), 1848-1859.","year":2022,"type":"Journal Article (Original Article)"},{"title":"B\u00fchrer, E., Amrein, M. A., Forster, S., Isringhausen, S., Sch\u00fcrch, C., Bhate, S. S., Brodie, T. M., Zindel, J., Keogh-Stroka, D. M., Al Sayed, M., Nombela-Arrieta, C., Radpour, R., Riether, C., \u0026 Ochsenbein, A. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/87773\u0022\u003ESplenic red pulp macrophages provide a niche for CML stem cells and induce therapy resistance\u003C\/a\u003E. \u003Ci\u003ELeukemia\u003C\/i\u003E, \u003Ci\u003E36\u003C\/i\u003E(11), 2634-2646.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Esposito, R., Polidori, T., Meise, D. F., Pulido Quetglas, C., Chouvardas, P., Forster, S., Schaerer, P., Kobel, A., Schlatter, J., Kerkhof, E., R\u00f6mmele, M., Rice, E. S., Zhu, L., Lanz\u00f3s, A., Guillen Ramirez, H. A., Basile, G., Carrozzo, I., Vancura, A. N., Ullrich, S., \u2026 Johnson, R. B. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/87919\u0022\u003EMulti-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilities\u003C\/a\u003E. \u003Ci\u003ECell Genomics\u003C\/i\u003E, \u003Ci\u003E2\u003C\/i\u003E(9), 100171.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Deng, H., Gao, Y., Trappetti, V., Hertig, D., Karatkevich, D., Losmanov\u00e1, T., Urz\u00ec, C., Ge, H., van Geest, G. A., Bruggmann, R., Djonov, V. G., Nuoffer, J.-M., Vermathen, P., Zamboni, N., Riether, C., Ochsenbein, A., Peng, R.-W., Kocher, G., Schmid, R., \u2026 Marti, T. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/86329\u0022\u003ETargeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtDNA damage\u003C\/a\u003E. \u003Ci\u003ECellular and Molecular Life Sciences\u003C\/i\u003E, \u003Ci\u003E79\u003C\/i\u003E(8), 445.","year":2022,"type":"Journal Article (Original Article)"},{"title":"K\u00f6nig, D., Sch\u00e4r, S., Vuong, D., Guckenberger, M., Furrer, K., Opitz, I., Weder, W., Rothschild, S. I., Ochsenbein, A., Zippelius, A., Addeo, A., Mark, M., Eboulet, E. I., Hayoz, S., Thierstein, S., Betticher, D. C., Ris, H.-B., Stupp, R., Curioni-Fontecedro, A., \u2026 Fr\u00fch, M. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/70356\u0022\u003ECorrigendum to \u2019Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16\/96, SAKK 16\/00, SAKK 16\/01, and SAKK 16\/08 trials\u2019: [ESMO Open Volume 7, Issue 2, (2022), 100455]\u003C\/a\u003E. \u003Ci\u003EESMO Open\u003C\/i\u003E, \u003Ci\u003E7\u003C\/i\u003E(3), 100494.","year":2022,"type":"Journal Article (Further Contribution)"},{"title":"K\u00f6nig, D., Sch\u00e4r, S., Vuong, D., Guckenberger, M., Furrer, K., Opitz, I., Weder, W., Rothschild, S. I., Ochsenbein, A., Zippelius, A., Addeo, A., Mark, M., Eboulet, E. I., Hayoz, S., Thierstein, S., Betticher, D. C., Ris, H.-B., Stupp, R., Curioni-Fontecedro, A., \u2026 Fr\u00fch, M. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/70133\u0022\u003ELong-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16\/96, SAKK 16\/00, SAKK 16\/01, and SAKK 16\/08 trials\u003C\/a\u003E. \u003Ci\u003EESMO Open\u003C\/i\u003E, \u003Ci\u003E7\u003C\/i\u003E(2), 100455.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Haas, Q., Markov, N., M\u00fcrner, L. D., Rubino, V., Benjak, A., Haubitz, M., B\u00e4rlocher, G. M., Ng, K. Y. C., M\u00fcnz, C., Riether, C., Ochsenbein, A., Simon, H.-U., \u0026 von Gunten, S. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/88008\u0022\u003ESiglec-7 represents a glyco-immune checkpoint for non-exhausted effector memory CD8+ T cells with high functional and metabolic capacities\u003C\/a\u003E. \u003Ci\u003EFrontiers in Immunology\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E, 996746.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Hinterbrandner, M., Rubino, V., Stoll, C. M., Forster, S., Schn\u00fcriger, N. S., Radpour, R., B\u00e4rlocher, G. M., Ochsenbein, A., \u0026 Riether, C. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/54248\u0022\u003ETnfrsf4-expressing regulatory T cells promote immune escape of chronic myeloid leukemia stem cells\u003C\/a\u003E. \u003Ci\u003EJCI Insight\u003C\/i\u003E, \u003Ci\u003E6\u003C\/i\u003E(23).","year":2021,"type":"Journal Article (Original Article)"},{"title":"Rothschild, S. I., Zippelius, A., Eboulet, E. I., Savic Prince, S., Betticher, D., Bettini, A., Fr\u00fch, M., Joerger, M., Lardinois, D., Gelpke, H., Mauti, L. A., Britschgi, C., Weder, W., Peters, S., Mark, M., Cathomas, R., Ochsenbein, A., Janthur, W.-D., Waibel, C., \u2026 Pless, M. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/190500\u0022\u003ESAKK 16\/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II Trial\u003C\/a\u003E. \u003Ci\u003EJournal of Clinical Oncology\u003C\/i\u003E, \u003Ci\u003E39\u003C\/i\u003E(26), 2872-2880.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Zens, P. I., Bello, C. M., Scherz, A., Koenigsdorf, J., P\u00f6llinger, A., Schmid, R., Ochsenbein, A., Neppl, C., Langer, R., \u0026 Berezowska, S. A. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/56452\u0022\u003EA prognostic score for non-small cell lung cancer resected after neoadjuvant therapy in comparison with the tumor-node-metastases classification and major pathological response\u003C\/a\u003E. \u003Ci\u003EModern Pathology\u003C\/i\u003E, \u003Ci\u003E34\u003C\/i\u003E(7), 1333-1344.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Amrein, M. A., B\u00fchrer, E., Amrein, M. L., Li, Q., Rothschild, S., Riether, C., Jaggi, R., Savic-Prince, S., Bubendorf, L., Gautschi, O., \u0026 Ochsenbein, A. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/55255\u0022\u003EChemotherapy negatively impacts the tumor immune microenvironment in NSCLC: an analysis of pre- and post-treatment biopsies in the multi-center SAKK19\/09 study\u003C\/a\u003E. \u003Ci\u003ECancer Immunology, Immunotherapy : CII\u003C\/i\u003E, \u003Ci\u003E70\u003C\/i\u003E(2), 405-415.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Riether, C., Radpour, R., Kallen, N. M., B\u00fcrgin, D. T., Bachmann, C. L., Sch\u00fcrch, C. M., L\u00fcthi, U., Arambasic, M., Hoppe, S., Albers, C., B\u00e4rlocher, G. M., \u0026 Ochsenbein, A. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/45583\u0022\u003EMetoclopramide treatment blocks CD93-signaling-mediated self-renewal of chronic myeloid leukemia stem cells\u003C\/a\u003E. \u003Ci\u003ECell Reports\u003C\/i\u003E, \u003Ci\u003E34\u003C\/i\u003E(4), 108663.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Radpour, R., Stucki, M., Riether, C., \u0026 Ochsenbein, A. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/45777\u0022\u003EEpigenetic Silencing of Immune-Checkpoint Receptors in Bone Marrow- Infiltrating T Cells in Acute Myeloid Leukemia\u003C\/a\u003E. \u003Ci\u003EFrontiers in Oncology\u003C\/i\u003E, \u003Ci\u003E11\u003C\/i\u003E, 663406.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Wirsching, H.-G., Roelcke, U., Weller, J., Hundsberger, T., Hottinger, A. F., von Moos, R., Caparrotti, F., Conen, K., Remonda, L., Roth, P., Ochsenbein, A., Tabatabai, G., \u0026 Weller, M. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/57644\u0022\u003EMRI and 18FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial\u003C\/a\u003E. \u003Ci\u003EClinical Cancer Research\u003C\/i\u003E, \u003Ci\u003E27\u003C\/i\u003E(1), 179-188.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Riether, C., Pabst, T. N., H\u00f6pner, S., Bacher, V. U., Hinterbrandner, M., Banz W\u00e4lti, Y. S., M\u00fcller, R., Manz, M. G., Gharib, W., Ferreira Francisco, D. M., Bruggmann, R., van Rompaey, L., Moshir, M., Delahaye, T., Gandini, D., Erzeel, E., Hultberg, A., Fung, S., de Haard, H., \u2026 Ochsenbein, A. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/55076\u0022\u003ETargeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents\u003C\/a\u003E. \u003Ci\u003ENature Medicine\u003C\/i\u003E, \u003Ci\u003E26\u003C\/i\u003E(9), 1459-1467.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Riether, C., \u0026 Ochsenbein, A. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/44966\u0022\u003EGenetic Alterations Impact Immune Microenvironment Interactions in Follicular Lymphoma\u003C\/a\u003E. \u003Ci\u003ECancer Cell\u003C\/i\u003E, \u003Ci\u003E37\u003C\/i\u003E(5), 621-622.","year":2020,"type":"Journal Article (Further Contribution)"},{"title":"Ruckstuhl, C. A., Hinterbrandner, M., H\u00f6pner, S., Correnti, C. E., L\u00fcthi, U., Friedli, O., Freigang, S., Al Sayed, M. F., B\u00fchrer, E., Amrein, M. A., Sch\u00fcrch, C., Radpour, R., Riether, C., \u0026 Ochsenbein, A. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/55196\u0022\u003ETNIK signaling imprints CD8+ T cell memory formation early after priming\u003C\/a\u003E. \u003Ci\u003ENature Communications\u003C\/i\u003E, \u003Ci\u003E11\u003C\/i\u003E(1), 1632.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Koll\u00e1r, A., B\u00fctikofer, L., Ochsenbein, A., Stettler, C., \u0026 Trepp, R. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/186372\u0022\u003ETreatment sequence in patients with neuroendocrine tumours: a nationwide multicentre, observational analysis of the Swiss neuroendocrine tumour registry\u003C\/a\u003E. \u003Ci\u003ESwiss Medical Weekly\u003C\/i\u003E, \u003Ci\u003E150\u003C\/i\u003E, w20176.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Salom\u00e9, B., Gomez-Cadena, A., Loyon, R., Suffiotti, M., Salvestrini, V., Wyss, T., Vanoni, G., Ruan, D. F., Rossi, M., Tozzo, A., Tentorio, P., Bruni, E., Riether, C., Jacobsen, E.-M., Jandus, P., Conrad, C., Hoenig, M., Schulz, A., Michaud, K., \u2026 Jandus, C. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/184505\u0022\u003ECD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML\u003C\/a\u003E. \u003Ci\u003EBlood Advances\u003C\/i\u003E, \u003Ci\u003E3\u003C\/i\u003E(22), 3674-3687.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Al Sayed, M., Amrein, M. L., B\u00fchrer, E., Huguenin, A., Radpour, R., Riether, C., \u0026 Ochsenbein, A. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62935\u0022\u003ET-cell-Secreted TNF\u03b1 Induces Emergency Myelopoiesis and Myeloid-Derived Suppressor Cell Differentiation in Cancer\u003C\/a\u003E. \u003Ci\u003ECancer Research\u003C\/i\u003E, \u003Ci\u003E79\u003C\/i\u003E(2), 346-359.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Radpour, R., Riether, C., Simillion, C., H\u00f6pner, S., Bruggmann, R., \u0026 Ochsenbein, A. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/182824\u0022\u003ECD8+ T cells expand stem and progenitor cells in favorable but not adverse risk acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003ELeukemia\u003C\/i\u003E, \u003Ci\u003E33\u003C\/i\u003E(10), 2379-2392.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Ti\u00e8che, C., Gao, Y., B\u00fchrer, E., Hobi, N., Berezowska, S. A., Wyler, K., Froment, L., Weis, S., Peng, R.-W., Bruggmann, R., Sch\u00e4r, P., Amrein, M. A., Hall, S., Dorn, P., Kocher, G., Riether, C., Ochsenbein, A., Schmid, R., \u0026 Marti, T. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62201\u0022\u003ETumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549\u003C\/a\u003E. \u003Ci\u003ENeoplasia\u003C\/i\u003E, \u003Ci\u003E21\u003C\/i\u003E(2), 185-196.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Fr\u00fch, M., Betticher, D. C., Stupp, R., Xyrafas, A., Peters, S., Ris, H. B., Mirimanoff, R. O., Ochsenbein, A., Schmid, R., Matzinger, O., Stahel, R. A., Weder, W., Guckenberger, M., Rothschild, S. I., Lardinois, D., Mach, N., Mark, M., Gautschi, O., Thierstein, S., \u2026 Pless, M. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/183015\u0022\u003EMultimodal Treatment in Operable Stage III NSCLC: A Pooled Analysis on Long-Term Results of Three SAKK trials (SAKK 16\/96, 16\/00, and 16\/01)\u003C\/a\u003E. \u003Ci\u003EJournal of Thoracic Oncology\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(1), 115-123.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Shun-Qing, L., B\u00fchrer, E., Berezowska, S. A., Marti, T., Xu, D., Froment, L., Yang, H., Hall, S., Vassella, E., Zhang, Y., Kocher, G., Amrein, M. A., Riether, C., Ochsenbein, A., Schmid, R., \u0026 Peng, R.-W. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/60122\u0022\u003EmTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer\u003C\/a\u003E. \u003Ci\u003EOncogene\u003C\/i\u003E, \u003Ci\u003E38\u003C\/i\u003E(5), 622-636.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Riether, C., Pabst, T. N., H\u00f6pner, S., Bacher, V. U., Hinterbrandner, M., Banz W\u00e4lti, Y. S., M\u00fcller, R., Manz, M. G., Gharib, W. H., Ferreira Francisco, D. M., Bruggmann, R., Van Rompaey, L., Moshir, M., Delahaye, T., Gandini, D., Erzeel, E., Hultberg, A., Fung, S., De Haard, H., \u2026 Ochsenbein, A. (2018). \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/180990\u0022\u003E2680 Argx-110 Targeting CD70, in Combination with Azacitidine, Shows Favorable Safety Profile and Promising Anti-Leukemia Activity in Newly Diagnosed AML Patients in an Ongoing Phase 1\/2 Clinical Trial\u003C\/a\u003E\u003C\/i\u003E. ASCO 2018. BORIS Portal.","year":2018,"type":"Conference Paper"},{"title":"Hilmenyuk, T., Ruckstuhl, C. A., Hayoz, M., Berchtold, C., Nuoffer, J.-M., Solanki, S., Keun, H. C., Beavis, P. A., Riether, C., \u0026 Ochsenbein, A. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/157584\u0022\u003ET cell inhibitory mechanisms in a model of aggressive Non-Hodgkin\u2019s Lymphoma\u003C\/a\u003E. \u003Ci\u003EOncoimmunology\u003C\/i\u003E, \u003Ci\u003E7\u003C\/i\u003E(1), e1365997.","year":2018,"type":"Journal Article (Original Article)"},{"title":"Rothschild, S., Amrein, M. A., Riether, C., Gautschi, O., Schuster, N., Li, Q., Savic, S., Schneider, M., Biaggi, C., Bubendorf, L., Brutsche, M., Zippelius, A., Zander, T., Betticher, D., Fr\u00fch, M., Stahel, R., Cathomas, R., Rauch, D., Pless, M., \u2026 Jaggi, R. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/158457\u0022\u003ECCNE1, PTGS2, TGFA and WISP2 Predict Benefit from Bevacizumab and Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer (SAKK19\/09)\u003C\/a\u003E. In \u003Ci\u003EJournal of thoracic oncology\u003C\/i\u003E (Vols. 12, Issue 11S2, pp. S1864-S1865). World Conference on Lung Cancer. Elsevier.","year":2017,"type":"Conference Paper"},{"title":"Al Sayed, M., Ruckstuhl, C. A., Hilmenyuk, T., Claus, C., Bourquin, J.-P., Bornhauser, B. C., Radpour, R., Riether, C., \u0026 Ochsenbein, A. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/158345\u0022\u003ECD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E130\u003C\/i\u003E(3), 297-309.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Gautschi, O., Rothschild, S. I., Li, Q., Matter-Walstra, K., Zippelius, A., Betticher, D. C., Fr\u00fch, M., Stahel, R. A., Cathomas, R., Rauch, D., Pless, M., Peters, S., Froesch, P., Zander, T., Schneider, M., Biaggi, C., Mach, N., \u0026 Ochsenbein, A. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/147421\u0022\u003EBevacizumab Plus Pemetrexed Versus Pemetrexed Alone as Maintenance Therapy for Patients With Advanced Nonsquamous Non-Small-cell Lung Cancer: Update From the Swiss Group for Clinical Cancer Research (SAKK) 19\/09 Trial\u003C\/a\u003E. \u003Ci\u003EClinical Lung Cancer\u003C\/i\u003E, \u003Ci\u003E18\u003C\/i\u003E(3), 303-309.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Riether, C., Sch\u00fcrch, C., B\u00fchrer, E., Hinterbrandner, M., Huguenin, A.-L., H\u00f6pner, S., Zlobec, I., Pabst, T. N., Radpour, R., \u0026 Ochsenbein, A. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/148651\u0022\u003ECD70\/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia\u003C\/a\u003E. \u003Ci\u003EThe Journal of Experimental Medicine\u003C\/i\u003E, \u003Ci\u003E214\u003C\/i\u003E(2), 359-380.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Zysset, D., Weber, B., Rihs, S., Brasseit, J., Freigang, S., Riether, C., Banz W\u00e4lti, Y. S., Cerwenka, A., Simillion, C., Marques-Vidal, P., Ochsenbein, A., Saurer, L., \u0026 M\u00fcller, C. (2016). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/147410\u0022\u003ETREM-1 links dyslipidemia to inflammation and lipid deposition in atherosclerosis\u003C\/a\u003E. \u003Ci\u003ENature Communications\u003C\/i\u003E, \u003Ci\u003E7\u003C\/i\u003E(13151), 13151.","year":2016,"type":"Journal Article (Original Article)"},{"title":"Gautschi, O., Li, Q., Matter-Walstra, K., Betticher, D., Frueh, M., Rauch, D., Pless, M., Froesch, P., Mach, N., \u0026 Ochsenbein, A. (2016). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/147422\u0022\u003E143PD: Bevacizumab and pemetrexed versus pemetrexed alone as maintenance therapy for patients with advanced nonsquamous NSCLC: Results of the expanded SAKK19\/09 trial\u003C\/a\u003E. \u003Ci\u003EJournal of Thoracic Oncology\u003C\/i\u003E, \u003Ci\u003E11\u003C\/i\u003E(4Suppl), S120.","year":2016,"type":"Journal Article (Original Article)"},{"title":"Gross, S., Lennerz, V., Gallerani, E., Mach, N., B\u00f6hm, S., Hess, D., von Boehmer, L., Knuth, A., Ochsenbein, A., Gnad-Vogt, U., Forssmann, U., Woelfel, T., \u0026 Kaempgen, E. (2016). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/139014\u0022\u003EShort Peptide Vaccine Induces CD4+ T Helper Cells in Patients with Different Solid Cancers\u003C\/a\u003E. \u003Ci\u003ECancer Immunology Research\u003C\/i\u003E, \u003Ci\u003E4\u003C\/i\u003E(1), 18-25.","year":2016,"type":"Journal Article (Original Article)"},{"title":"Stahel, R. A., Riesterer, O., Xyrafas, A., Opitz, I., Beyeler, M., Ochsenbein, A., Fr\u00fch, M., Cathomas, R., Nackaerts, K., Peters, S., Mamot, C., Zippelius, A., Mordasini, C., Caspar, C. B., Eckhardt, K., Schmid, R., Aebersold, D. M., Gautschi, O., Nagel, W., \u2026 Weder, W. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/137724\u0022\u003ENeoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17\/04): a randomised, international, multicentre phase 2 trial\u003C\/a\u003E. \u003Ci\u003EThe Lancet Oncology\u003C\/i\u003E, \u003Ci\u003E16\u003C\/i\u003E(16), 1651-1658.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Pless, M., Stupp, R., Ris, H.-B., Stahel, R. A., Weder, W., Thierstein, S., Gerard, M.-A., Xyrafas, A., Fr\u00fch, M., Cathomas, R., Zippelius, A., Roth, A., Bijelovic, M., Ochsenbein, A., Meier, U. R., Mamot, C., Rauch, D., Gautschi, O., Betticher, D. C., \u2026 Peters, S. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/139016\u0022\u003EInduction chemoradiation in stage IIIA\/N2 non-small-cell lung cancer: a phase 3 randomised trial\u003C\/a\u003E. \u003Ci\u003ELancet\u003C\/i\u003E, \u003Ci\u003E386\u003C\/i\u003E(9998), 1049-1056.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Riether, C., Gschwend, T., Huguenin, A.-L., Sch\u00fcrch, C., \u0026 Ochsenbein, A. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/139030\u0022\u003EBlocking programmed cell death 1 in combination with adoptive cytotoxic T-cell transfer eradicates chronic myelogenous leukemia stem cells\u003C\/a\u003E. \u003Ci\u003ELeukemia\u003C\/i\u003E, \u003Ci\u003E29\u003C\/i\u003E(8), 1781-1785.","year":2015,"type":"Journal Article (Further Contribution)"},{"title":"Riether, C., Sch\u00fcrch, C., Flury, C., Hinterbrandner, M., Dr\u00fcck, L., Huguenin, A.-L., Baerlocher, G. M., Radpour, R., \u0026 Ochsenbein, A. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/192593\u0022\u003ETyrosine kinase inhibitor-induced CD70 expression mediates drug resistance in leukemia stem cells by activating Wnt signaling\u003C\/a\u003E. \u003Ci\u003EScience Translational Medicine\u003C\/i\u003E, \u003Ci\u003E7\u003C\/i\u003E(298), 298ra119.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Mager, L., Riether, C., Sch\u00fcrch, C., Banz W\u00e4lti, Y. S., Wasmer, M.-H. C., Stuber Roos, R., Theocharides, A., Li, X., Xia, Y., Saito, H., Nakae, S., Baerlocher, G. M., Manz, M. G., McCoy, K., Macpherson, A., Ochsenbein, A., Beutler, B., \u0026 Krebs, P. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/192510\u0022\u003EIL-33 signaling contributes to the pathogenesis of myeloproliferative neoplasms\u003C\/a\u003E. \u003Ci\u003EJournal of Clinical Investigation\u003C\/i\u003E, \u003Ci\u003E125\u003C\/i\u003E(7), 2579-2591.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Galli, S., Zlobec, I., Sch\u00fcrch, C., Perren, A., Ochsenbein, A., \u0026 Banz W\u00e4lti, Y. S. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/134164\u0022\u003ECD47 protein expression in acute myeloid leukemia: A tissue microarray-based analysis\u003C\/a\u003E. \u003Ci\u003ELeukemia Research\u003C\/i\u003E, \u003Ci\u003E39\u003C\/i\u003E(7), 749-756.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Trabanelli, S., Curti, A., Lecciso, M., Salom\u00e9, B., Riether, C., Ochsenbein, A., Romero, P., \u0026 Jandus, C. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/139029\u0022\u003ECD127+ innate lymphoid cells are dysregulated in treatment na\u00efve acute myeloid leukemia patients at diagnosis\u003C\/a\u003E. \u003Ci\u003EHaematologica - the Hematology Journal\u003C\/i\u003E, \u003Ci\u003E100\u003C\/i\u003E(7), e257-e260.","year":2015,"type":"Journal Article (Further Contribution)"},{"title":"Hunger, R., Angermeier, S., Seyed Jafari, S. M., Ochsenbein, A., \u0026 Shafighi, M. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/138346\u0022\u003EA retrospective study of 1- versus 2-cm excision margins for cutaneous malignant melanomas thicker than 2 mm\u003C\/a\u003E. \u003Ci\u003EJournal of the American Academy of Dermatology\u003C\/i\u003E, \u003Ci\u003E72\u003C\/i\u003E(6), 1054-1059.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Koll\u00e1r, A., Hewer, E. W., Kellner-Weldon, F., \u0026 Ochsenbein, A. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/128423\u0022\u003EComplete pain relief after bevacizumab in a patient with neurofibromatosis type 2\u003C\/a\u003E. \u003Ci\u003EActa Oncologica\u003C\/i\u003E, \u003Ci\u003E54\u003C\/i\u003E(2), 280-288.","year":2015,"type":"Journal Article (Further Contribution)"},{"title":"Riether, C., Sch\u00fcrch, C., \u0026 Ochsenbein, A. (2015). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/129051\u0022\u003ERegulation of hematopoietic and leukemic stem cells by the immune system.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ECell Death and Differentiation\u003C\/i\u003E, \u003Ci\u003E22\u003C\/i\u003E(2), 187-198.","year":2015,"type":"Journal Article (Review)"},{"title":"Gautschi, O., Mach, N., Rothschild, S., Li, Q., Stahel, R. A., Zippelius, A., Cathomas, R., Fr\u00fch, M., Betticher, D. C., Peters, S., Rauch, D., Feilchenfeldt, J., Bubendorf, L., Savic, S., Jaggi, R., Oppliger Leibundgut, E., Largiad\u00e8r, C. R., Brutsche, M., Pilop, C., \u2026 Ochsenbein, A. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/135187\u0022\u003EBevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19\/09\u003C\/a\u003E. \u003Ci\u003EClinical Lung Cancer\u003C\/i\u003E, \u003Ci\u003E16\u003C\/i\u003E(5), 358-365.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Balmer, M. L., Sch\u00fcrch, C., Saito, Y., Geuking, M., Li, H., Cuenca Vera, M., Kovtonyuk, L. V., McCoy, K., Hapfelmeier, S. H., Ochsenbein, A., Manz, M. G., Slack, E., \u0026 Macpherson, A. (2014). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/129049\u0022\u003EMicrobiota-derived compounds drive steady-state granulopoiesis via MyD88\/TICAM signaling\u003C\/a\u003E. \u003Ci\u003EJournal of Immunology\u003C\/i\u003E, \u003Ci\u003E193\u003C\/i\u003E(10), 5273-5283.","year":2014,"type":"Journal Article (Original Article)"},{"title":"J\u00f6rger, M., Baty, F., Fr\u00fch, M., Stahel, R. A., Betticher, D. C., von Moos, R., Ochsenbein, A., Pless, M., Gautschi, O., Rothschild, S., Brauchli, P., Klingbiel, D., Zappa, F., \u0026 Brutsche, M. (2014). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/129054\u0022\u003ECirculating microRNA profiling in patients with advanced non-squamous NSCLC receiving bevacizumab\/erlotinib followed by platinum-based chemotherapy at progression (SAKK 19\/05)\u003C\/a\u003E. \u003Ci\u003ELung Cancer\u003C\/i\u003E, \u003Ci\u003E85\u003C\/i\u003E(2), 306-313.","year":2014,"type":"Journal Article (Original Article)"},{"title":"Sch\u00fcrch, C., Riether, C., \u0026 Ochsenbein, A. (2014). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/129055\u0022\u003ECytotoxic CD8+ T cells stimulate hematopoietic progenitors by promoting cytokine release from bone marrow mesenchymal stromal cells\u003C\/a\u003E. \u003Ci\u003ECell Stem Cell\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(4), 460-472.","year":2014,"type":"Journal Article (Original Article)"},{"title":"Lennerz, V., Gross, S., Gallerani, E., Sessa, C., Mach, N., Boehm, S., Hess, D., von Boehmer, L., Knuth, A., Ochsenbein, A., Gnad-Vogt, U., Zieschang, J., Forssmann, U., Woelfel, T., \u0026 Kaempgen, E. (2014). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/129057\u0022\u003EImmunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors\u003C\/a\u003E. \u003Ci\u003ECancer Immunology, Immunotherapy\u003C\/i\u003E, \u003Ci\u003E63\u003C\/i\u003E(4), 381-394.","year":2014,"type":"Journal Article (Original Article)"},{"title":"Eisele, G., Wick, A., Eisele, A.-C., Cl\u00e9ment, P. M., Tonn, J., Tabatabai, G., Ochsenbein, A., Schlegel, U., Neyns, B., Krex, D., Langenegger, S. M., Nikkhah, G., Picard, M., Stupp, R., Wick, W., \u0026 Weller, M. (2014). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/129059\u0022\u003ECilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression\u003C\/a\u003E. \u003Ci\u003EJournal of Neuro-Oncology\u003C\/i\u003E, \u003Ci\u003E117\u003C\/i\u003E(1), 141-145.","year":2014,"type":"Journal Article (Original Article)"},{"title":"Weber, B., Schuster, S., Zysset, D., Rihs, S., Dickgreber, N., Sch\u00fcrch, C., Riether, C., Siegrist, M., Schneider, C., Pawelski, H., Gurzeler, U., Ziltener, P., Genitsch Gratwohl, V., Tacchini-Cottier, F., Ochsenbein, A., Hofstetter-Jenny, W., Kopf, M., Kaufmann, T., Oxenius, A., \u2026 M\u00fcller, C. (2014). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/117719\u0022\u003ETREM-1 deficiency can attenuate disease severity without affecting pathogen clearance\u003C\/a\u003E. \u003Ci\u003EPLoS Pathogens\u003C\/i\u003E, \u003Ci\u003E10\u003C\/i\u003E(1), e1003900.","year":2014,"type":"Journal Article (Original Article)"},{"title":"Sch\u00fcrch, C., Riether, C., \u0026 Ochsenbein, A. (2013). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/117030\u0022\u003EDendritic Cell-Based Immunotherapy for Myeloid Leukemias\u003C\/a\u003E. \u003Ci\u003EFrontiers in Immunology\u003C\/i\u003E, \u003Ci\u003E4\u003C\/i\u003E(496), 496.","year":2013,"type":"Journal Article (Original Article)"},{"title":"Sch\u00fcrch, C., Riether, C., \u0026 Ochsenbein, A. (2013). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/117031\u0022\u003EInterferons in hematopoiesis and leukemia\u003C\/a\u003E. \u003Ci\u003EOncoimmunology\u003C\/i\u003E, \u003Ci\u003E2\u003C\/i\u003E(6), e24572.","year":2013,"type":"Journal Article (Further Contribution)"},{"title":"Sch\u00fcrch, C., Riether, C., Amrein, M. A., \u0026 Ochsenbein, A. (2013). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/117033\u0022\u003ECytotoxic T cells induce proliferation of chronic myeloid leukemia stem cells by secreting interferon-\u03b3\u003C\/a\u003E. \u003Ci\u003EJournal of Experimental Medicine\u003C\/i\u003E, \u003Ci\u003E210\u003C\/i\u003E(3), 605-621.","year":2013,"type":"Journal Article (Original Article)"},{"title":"Riether, C., Sch\u00fcrch, C., \u0026 Ochsenbein, A. (2013). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/117035\u0022\u003EFrom \u0022magic bullets\u0022 to specific cancer immunotherapy\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ESwiss Medical Weekly\u003C\/i\u003E, \u003Ci\u003E143\u003C\/i\u003E, w13734.","year":2013,"type":"Journal Article (Review)"},{"title":"Schoenewolf, N. L., Dummer, R., Mihic-Probst, D., Moch, H., Simcock, M., Ochsenbein, A., Gillessen, S., Schraml, P., von Moos, R., \u0026 Swiss Group for Clinical Cancer Research, (SAKK). (2012). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/84338\u0022\u003EDetecting BRAF Mutations in Formalin-Fixed Melanoma: Experiences with Two State-of-the-Art Techniques\u003C\/a\u003E. \u003Ci\u003ECase Reports in Oncology\u003C\/i\u003E, \u003Ci\u003E5\u003C\/i\u003E(2), 280-9.","year":2012,"type":"Journal Article (Original Article)"},{"title":"Zappa, F., Droege, C., Betticher, D., von Moos, R., Bubendorf, L., Ochsenbein, A., Gautschi, O., Oppliger Leibundgut, E., Froesch, P., Stahel, R., Hess, T., Rauch, D., Schmid, P., Mayer, M., Crowe, S., Brauchli, P., Ribi, K., Pless, M., \u0026 on behalf of the Swiss Group for Clinical Cancer Research (SAKK). (2012). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/80609\u0022\u003EBevacizumab and erlotinib (BE) first-line therapy in advanced non-squamous non-small-cell lung cancer (NSCLC) (stage IIIB\/IV) followed by platinum-based chemotherapy (CT) at disease progression: A multicenter phase II trial (SAKK 19\/05)\u003C\/a\u003E. \u003Ci\u003ELung Cancer\u003C\/i\u003E, \u003Ci\u003E78\u003C\/i\u003E(3), 239-44.","year":2012,"type":"Journal Article (Original Article)"},{"title":"Schraml, P., von Teichman, A., Mihic-Probst, D., Simcock, M., Ochsenbein, A., Dummer, R., Michielin, O., Seifert, B., Schl\u00e4ppi, M., Moch, H., \u0026 von Moos, R. (2012). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/84339\u0022\u003EPredictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50\/07\u003C\/a\u003E. \u003Ci\u003EOncology Reports\u003C\/i\u003E, \u003Ci\u003E28\u003C\/i\u003E(2), 654-8.","year":2012,"type":"Journal Article (Original Article)"},{"title":"Fahrner, R., Ochsenbein, A., Schmid, R., \u0026 Carboni, G. L. (2012). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/84337\u0022\u003ELong term survival after trimodal therapy in malignant pleural mesothelioma\u003C\/a\u003E. \u003Ci\u003ESwiss Medical Weekly\u003C\/i\u003E, \u003Ci\u003E142\u003C\/i\u003E, w13686.","year":2012,"type":"Journal Article (Original Article)"},{"title":"Sch\u00fcrch, C., Riether, C., Matter, M. S., Tzankov, A., \u0026 Ochsenbein, A. (2012). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/76974\u0022\u003ECD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression\u003C\/a\u003E. \u003Ci\u003EJournal of Clinical Investigation\u003C\/i\u003E, \u003Ci\u003E122\u003C\/i\u003E(2), 624-38.","year":2012,"type":"Journal Article (Original Article)"},{"title":"von Moos, R., Seifert, B., Simcock, M., Goldinger, S. M., Gillessen, S., Ochsenbein, A., Michielin, O., Cathomas, R., Schl\u00e4ppi, M., Moch, H., Schraml, P. H., Mjhic-Probst, D., Mamot, C., Sch\u00f6newolf, N., Dummer, R., \u0026 Swiss Group for Clinical Cancer Research, (SAKK). (2012). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/76976\u0022\u003EFirst-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50\/07)\u003C\/a\u003E. \u003Ci\u003EAnnals of Oncology\u003C\/i\u003E, \u003Ci\u003E23\u003C\/i\u003E(2), 531-6.","year":2012,"type":"Journal Article (Original Article)"},{"title":"Claus, C., Riether, C., Sch\u00fcrch, C., Matter, M. S., Hilmenyuk, T., \u0026 Ochsenbein, A. (2012). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/82864\u0022\u003ECD27 signaling increases the frequency of regulatory T cells and promotes tumor growth\u003C\/a\u003E. \u003Ci\u003ECancer Research\u003C\/i\u003E, \u003Ci\u003E72\u003C\/i\u003E(14), 3664-76.","year":2012,"type":"Journal Article (Original Article)"},{"title":"Riether, C., Sch\u00fcrch, C., \u0026 Ochsenbein, A. (2012). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/82863\u0022\u003EModulating CD27 signaling to treat cancer\u003C\/a\u003E. \u003Ci\u003EOncoimmunology\u003C\/i\u003E, \u003Ci\u003E1\u003C\/i\u003E(9), 1604-1606.","year":2012,"type":"Journal Article (Original Article)"},{"title":"Hofer, S., Elandt, K., Greil, R., Hottinger, A. F., Huber, U., Lemke, D., Marosi, C., Ochsenbein, A., Pichler, J., Roelcke, U., Weder, P., Zander, T., Wick, W., \u0026 Weller, M. (2011). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/76977\u0022\u003EClinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials\u003C\/a\u003E. \u003Ci\u003EActa Oncologica\u003C\/i\u003E, \u003Ci\u003E50\u003C\/i\u003E(5), 630-5.","year":2011,"type":"Journal Article (Original Article)"},{"title":"Matter, M. S., Hilmenyuk, T., Claus, C., Marone, R., Sch\u00fcrch, C., Tinguely, M., Terracciano, L., Luther, S. A., \u0026 Ochsenbein, A. (2011). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/76975\u0022\u003EDestruction of lymphoid organ architecture and hepatitis caused by CD4+ T cells\u003C\/a\u003E. \u003Ci\u003EPLoS ONE\u003C\/i\u003E, \u003Ci\u003E6\u003C\/i\u003E(9), e24772.","year":2011,"type":"Journal Article (Original Article)"},{"title":"Ochsenbein, A., Schubert, A. D., Vassella, E., \u0026 Mariani, L. (2011). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/71551\u0022\u003EQuantitative analysis of O(6)-methylguanine DNA methyltransferase (MGMT) promoter methylation in patients with low-grade gliomas\u003C\/a\u003E. \u003Ci\u003EJournal of Neuro-Oncology\u003C\/i\u003E, \u003Ci\u003E103\u003C\/i\u003E(2), 343-51.","year":2011,"type":"Journal Article (Original Article)"},{"title":"Schlapbach, C., Ochsenbein, A., Kaelin, U., Hassan, A. S., Hunger, R., \u0026 Yawalkar, N. (2010). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/70992\u0022\u003EHigh numbers of DC-SIGN+ dendritic cells in lesional skin of cutaneous T-cell lymphoma\u003C\/a\u003E. \u003Ci\u003EJournal of the American Academy of Dermatology\u003C\/i\u003E, \u003Ci\u003E62\u003C\/i\u003E(6), 995-1004.","year":2010,"type":"Journal Article (Original Article)"},{"title":"Stupp, R., Hegi, M. E., Neyns, B., Goldbrunner, R., Schlegel, U., Clement, P. M. J., Grabenbauer, G. G., Ochsenbein, A., Simon, M., Dietrich, P.-Y., Pietsch, T., Hicking, C., Tonn, J.-C., Diserens, A.-C., Pica, A., Hermisson, M., Krueger, S., Picard, M., \u0026 Weller, M. (2010). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/71803\u0022\u003EPhase I\/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma\u003C\/a\u003E. \u003Ci\u003EJournal of Clinical Oncology\u003C\/i\u003E, \u003Ci\u003E28\u003C\/i\u003E(16), 2712-8.","year":2010,"type":"Journal Article (Original Article)"},{"title":"Flatz, L., Hegazy, A. N., Bergthaler, A., Verschoor, A., Claus, C., Fernandez, M., Gattinoni, L., Johnson, S., Kreppel, F., Kochanek, S., Broek, M. van den, Radbruch, A., L\u00e9vy, F., Lambert, P.-H., Siegrist, C.-A., Restifo, N. P., L\u00f6hning, M., Ochsenbein, A., Nabel, G. J., \u0026 Pinschewer, D. D. (2010). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/71822\u0022\u003EDevelopment of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity\u003C\/a\u003E. \u003Ci\u003ENature Medicine\u003C\/i\u003E, \u003Ci\u003E16\u003C\/i\u003E(3), 339-345.","year":2010,"type":"Journal Article (Original Article)"},{"title":"Mumprecht, S. B., Sch\u00fcrch, C., Scherrer, S., Claus, C., \u0026 Ochsenbein, A. (2010). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/71821\u0022\u003EChronic myelogenous leukemia maintains specific CD8(+) T cells through IL-7 signaling\u003C\/a\u003E. \u003Ci\u003EEuropean Journal of Immunology\u003C\/i\u003E, \u003Ci\u003E40\u003C\/i\u003E(10), 2720-2730.","year":2010,"type":"Journal Article (Original Article)"},{"title":"Pavelic, V., Matter, M. S., Mumprecht, S., Breyer, I., \u0026 Ochsenbein, A. (2009). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/104838\u0022\u003ECTL induction by cross-priming is restricted to immunodominant epitopes\u003C\/a\u003E. \u003Ci\u003EEuropean Journal of Immunology\u003C\/i\u003E, \u003Ci\u003E39\u003C\/i\u003E(3), 704-16.","year":2009,"type":"Journal Article (Original Article)"},{"title":"Mumprecht, S., Claus, C., Sch\u00fcrch, C., Pavelic, V., Matter, M. S., \u0026 Ochsenbein, A. (2009). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/104837\u0022\u003EDefective homing and impaired induction of cytotoxic T cells by BCR\/ABL-expressing dendritic cells\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E113\u003C\/i\u003E(19), 4681-9.","year":2009,"type":"Journal Article (Original Article)"},{"title":"Mumprecht, S. B., Sch\u00fcrch, C., Schwaller, J., Solenthaler, M., \u0026 Ochsenbein, A. (2009). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/104390\u0022\u003EProgrammed death 1 signaling on chronic myeloid leukemia-specific T cells results in T-cell exhaustion and disease progression\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E114\u003C\/i\u003E(8), 1528-1536.","year":2009,"type":"Journal Article (Original Article)"},{"title":"Matter, M., Claus, C., \u0026 Ochsenbein, A. (2008). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/100510\u0022\u003ECD4+ T cell help improves CD8+ T cell memory by retained CD27 expression\u003C\/a\u003E. \u003Ci\u003EEuropean Journal of Immunology\u003C\/i\u003E, \u003Ci\u003E38\u003C\/i\u003E(7), 1847-56.","year":2008,"type":"Journal Article (Original Article)"},{"title":"Matter, M., \u0026 Ochsenbein, A. (2008). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/100508\u0022\u003ENatural antibodies target virus-antibody complexes to organized lymphoid tissue\u003C\/a\u003E. \u003Ci\u003EAutoimmunity Reviews\u003C\/i\u003E, \u003Ci\u003E7\u003C\/i\u003E(6), 480-6.","year":2008,"type":"Journal Article (Further Contribution)"},{"title":"Ochsenbein, A., Chai, F., Winter, S., Traisnel, M., Breme, J., \u0026 Hildebrand, H. F. (2008). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/100511\u0022\u003EOsteoblast responses to different oxide coatings produced by the sol-gel process on titanium substrates\u003C\/a\u003E. \u003Ci\u003EActa Biomaterialia\u003C\/i\u003E, \u003Ci\u003E4\u003C\/i\u003E(5), 1506-17.","year":2008,"type":"Journal Article (Original Article)"},{"title":"Ho, C., Ochsenbein, A., Gautschi, O., \u0026 Davies, A. M. (2008). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/100509\u0022\u003EEarly clinical trial experience with vaccine therapies in non-small-cell lung cancer\u003C\/a\u003E. \u003Ci\u003EClinical Lung Cancer\u003C\/i\u003E, \u003Ci\u003E9 Suppl 1\u003C\/i\u003E, S20-S27.","year":2008,"type":"Journal Article (Further Contribution)"},{"title":"Matter, M., Pavelic, V., Pinschewer, D. D., Mumprecht, S., Eschli, B., Giroglou, T., von Laer, D., \u0026 Ochsenbein, A. (2007). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/96094\u0022\u003EDecreased tumor surveillance after adoptive T-cell therapy\u003C\/a\u003E. \u003Ci\u003ECancer Research\u003C\/i\u003E, \u003Ci\u003E67\u003C\/i\u003E(15), 7467-76.","year":2007,"type":"Journal Article (Original Article)"},{"title":"Cresto, N., Barth, A., Arnold, M., Weimann, R., Gschossmann, J., Ochsenbein, A., Kolotas, C., Peter, H.-J., \u0026 Schiemann, U. K. (2007). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/96095\u0022\u003EAussergew\u00f6hnliche Manifestation eines Magenkarzinoms mit Meningeosis carcinomatosa und spinaler Metastase\u003C\/a\u003E. \u003Ci\u003EMedizinische Klinik\u003C\/i\u003E, \u003Ci\u003E102\u003C\/i\u003E(3), 255-8.","year":2007,"type":"Journal Article (Further Contribution)"},{"title":"Matter, M., Odermatt, B., Yagita, H., Nuoffer, J.-M., \u0026 Ochsenbein, A. (2006). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/92776\u0022\u003EElimination of chronic viral infection by blocking CD27 signaling\u003C\/a\u003E. \u003Ci\u003EJournal of Experimental Medicine\u003C\/i\u003E, \u003Ci\u003E203\u003C\/i\u003E(9), 2145-55.","year":2006,"type":"Journal Article (Original Article)"},{"title":"Mumprecht, S., Matter, M., Pavelic, V., \u0026 Ochsenbein, A. (2006). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/92777\u0022\u003EImatinib mesylate selectively impairs expansion of memory cytotoxic T cells without affecting the control of primary viral infections\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E108\u003C\/i\u003E(10), 3406-13.","year":2006,"type":"Journal Article (Original Article)"},{"title":"Ochsenbein, A. (2005). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/162626\u0022\u003EImmunological ignorance of solid tumors\u003C\/a\u003E. \u003Ci\u003ESeminars in Immunopathology\u003C\/i\u003E, \u003Ci\u003E27\u003C\/i\u003E(1), 19-35.","year":2005,"type":"Journal Article (Original Article)"}]}